Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025
EQS-News: Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025
EQS-News: Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025
 Roctool Celebrates 25 Years of Expertise with Induction Heating Solutions at JEC World 2025
Roctool Celebrates 25 Years of Expertise with Induction Heating Solutions at JEC World 2025
Roctool Celebrates 25 Years of Expertise with Induction Heating Solutions at JEC World 2025
Dassault Systèmes’ 3DEXPERIENCE World 2025 to Explore the AI-Powered Generative Economy
Dassault Systèmes’ 3DEXPERIENCE World 2025 to Explore the AI-Powered Generative Economy


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced 3DEXPERIENCE World 2025, its annual event dedicated to the SOLIDWORKS and 3DEXPERIENCE platform user community, is taking

ABIONYX Pharma, winner of the France 2030 Plan’s “i-Démo” call for projects, awarded €8.7 million from the French government to fight against Sepsis, the 3rd leading cause of death worldwide
ABIONYX Pharma, winner of the France 2030 Plan’s “i-Démo” call for projects, awarded €8.7 million from the French government to fight against Sepsis, the 3rd leading cause of death worldwide


ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world’s only natural

Sensorion Announces Its Participation in Several Investor Conferences to be Held in March
Sensorion Announces Its Participation in Several Investor Conferences to be Held in March


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing

PATRIMOINE ET COMMERCE: 2024 ANNUAL RESULTS
PATRIMOINE ET COMMERCE: 2024 ANNUAL RESULTS
PATRIMOINE ET COMMERCE: 2024 ANNUAL RESULTS
ESKER: Implementation Of The Squeeze-Out For The Shares Of The Company
ESKER: Implementation Of The Squeeze-Out For The Shares Of The Company


Following the public tender offer initiated by



Boréal Bidco SAS


This press release has been prepared and published on 18 February 2025 pursuant to Article 237-3 III of the Autorité des

TotalEnergies Joins Forces with Air Liquide to Decarbonize its Refineries in Northern Europe with Green Hydrogen
TotalEnergies Joins Forces with Air Liquide to Decarbonize its Refineries in Northern Europe with Green Hydrogen


In line with its 2030 ambition to decarbonize the hydrogen used in its European refineries, TotalEnergies has signed agreements with Air Liquide to develop two projects in the Netherlands, for the

Sensorion Announces Its Participation In Several Congresses To Be Held In March
Sensorion Announces Its Participation In Several Congresses To Be Held In March


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing

TotalEnergies, Masdar and EPointZero Sign Framework for Action to Drive Clean Energy Access in Africa and Asia
TotalEnergies, Masdar and EPointZero Sign Framework for Action to Drive Clean Energy Access in Africa and Asia


Abu Dhabi Future Energy Company PJSC – Masdar, the UAE’s clean energy leader, TotalEnergies and EPointZero, the decarbonization arm of 2PointZero, a transformational global investment platform

TotalEnergies and ENI Sign an Agreement With Cyprus and Egypt for the Export of Cyprus Block 6 Gas Through Egypt
TotalEnergies and ENI Sign an Agreement With Cyprus and Egypt for the Export of Cyprus Block 6 Gas Through Egypt


In the presence of President of Egypt Abdel Fattah El-Sisi and President of Cyprus Níkos Christodoulídis, TotalEnergies and ENI, partners in Cyprus offshore Block 6 (TotalEnergies 50%, ENI 50%

Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech releases Universal Registration Document 2024
Sartorius Stedim Biotech releases Universal Registration Document 2024
Sartorius Stedim Biotech releases Universal Registration Document 2024
Prodware: Strong Growth Continues in 2024
Prodware: Strong Growth Continues in 2024
Prodware: Strong Growth Continues in 2024
FIGEAC AÉRO: NEW WIN IN THE US BRINGS ADDITIONAL EXPOSURE TO THE BOEING 737 MAX
FIGEAC AÉRO: NEW WIN IN THE US BRINGS ADDITIONAL EXPOSURE TO THE BOEING 737 MAX
FIGEAC AÉRO: NEW WIN IN THE US BRINGS ADDITIONAL EXPOSURE TO THE BOEING 737 MAX
Eutelsat and ATSS Renew Strategic Partnership for Premium Satellite Services Across the Middle East and North Africa (MENA)
Eutelsat and ATSS Renew Strategic Partnership for Premium Satellite Services Across the Middle East and North Africa (MENA)


Regulatory News:



Eutelsat Group (ISIN: FR0010221234 - Euronext Paris / London Stock Exchange: ETL) and Saudi Arabia’s Advanced Telecommunications Solutions and Services (ATSS) have renewed their

FIGEAC AÉRO: FINANCIAL CALENDAR
FIGEAC AÉRO: FINANCIAL CALENDAR
FIGEAC AÉRO: FINANCIAL CALENDAR
Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 48th Annual Midwinter Meeting
Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 48th Annual Midwinter Meeting


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss

Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting
Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting
Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting
Pernod Ricard: Determined to Navigate Current Cyclical Headwinds With Resilience and Agility
Pernod Ricard: Determined to Navigate Current Cyclical Headwinds With Resilience and Agility


Regulatory News:



Pernod Ricard (Paris:RI):



Press Release – Paris, 6 February 2025



H1 Organic Operating Margin expansion, despite Sales decline, amidst ongoing challenges in the US and

BILENDI: The latest version of Bilendi Discuss fully automates market research studies from initial objective to final report using AI
BILENDI: The latest version of Bilendi Discuss fully automates market research studies from initial objective to final report using AI
BILENDI: The latest version of Bilendi Discuss fully automates market research studies from initial objective to final report using AI
FIGEAC AÉRO: FIGEAC AÉRO NORTH AMERICA DRIVES FURTHER LOCAL GROWTH WITH A NEW BUSINESS JET WIN WITH GKN AEROSPACE
FIGEAC AÉRO: FIGEAC AÉRO NORTH AMERICA DRIVES FURTHER LOCAL GROWTH WITH A NEW BUSINESS JET WIN WITH GKN AEROSPACE
FIGEAC AÉRO: FIGEAC AÉRO NORTH AMERICA DRIVES FURTHER LOCAL GROWTH WITH A NEW BUSINESS JET WIN WITH GKN AEROSPACE
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Medidata Advances New Frontiers for Life Sciences Through Patient-Centric Experiences, AI-Powered Innovations, and New Patient Engaging Alliances
Medidata Advances New Frontiers for Life Sciences Through Patient-Centric Experiences, AI-Powered Innovations, and New Patient Engaging Alliances


Medidata, a Dassault Systèmes brand, reaffirms its vision and commitment to advancing the life sciences industry and transforming patient experiences across the entire clinical development process

Dassault Systèmes and Volkswagen Group Implement the 3DEXPERIENCE Platform to Optimize Vehicle Development
Dassault Systèmes and Volkswagen Group Implement the 3DEXPERIENCE Platform to Optimize Vehicle Development


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Volkswagen Group today announced a long-term partnership to advance Volkswagen Group’s digital infrastructure for state-of-the-art